Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-002838

Chief Business Officer gave up 6,421 shares (to pay taxes)

  • Chief Business Officer acquired 18,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Loerop James Chief Business Officer 2024-02-01 Option exercise +11,250 32,938 D
Loerop James Chief Business Officer 2024-02-01 Shares withheld for taxes −3,853 $1.20 $4,624 29,085 D
Loerop James Chief Business Officer 2024-02-01 Option exercise +7,500 36,585 D
Loerop James Chief Business Officer 2024-02-01 Shares withheld for taxes −2,568 $1.20 $3,082 34,017 D
Derivatives
Loerop James Chief Business Officer 2024-02-01 Option exercise · Restricted Stock Units −11,250 22,500 D
Loerop James Chief Business Officer 2024-02-01 Option exercise · Restricted Stock Unit −7,500 22,500 D
Loerop James Chief Business Officer 2024-02-01 Grant or award · Employee Stock Option (Right to Buy) +206,500 206,500 D
Loerop James Chief Business Officer 2024-02-01 Grant or award · Restricted Stock Units +59,000 59,000 D
Loerop James Chief Business Officer 2024-02-01 Grant or award · Restricted Stock Units +147,500 147,500 D
Loading xslF345X05/doc4.xml…